CBIO: Global clinical trials and major data milestones in 2027 will drive next-gen oncology combinations
A robust oncology pipeline is advancing, with global clinical trials for a PD-1/VEGF bispecific and ADCs, supported by a strategic partnership and strong financial position. Key data readouts are expected throughout 2027, guiding registration plans and further collaborations.Based on Crescent Bioph…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.